Dermatologic and Ophthalmic Drugs Advisory Committee
id:
dermatologic-and-ophthalmic-drugs-advisory-committee-285-858635
title:
Dermatologic and Ophthalmic Drugs Advisory Committee
text:
The Dermatologic And Ophthalmic Drugs Advisory Committee (DODAC) receives requests for technical and clinical evaluation of new drugs by the U.S. Food and Drug Administration (FDA). The committee, consisting of members from academic and clinical dermatology, ophthalmology, biostatistics, the general public, and the pharmaceutical industry, makes non-binding recommendations to both the CDER and CBER divisions of the FDA about the advisability of approving new medications to treat dermatologic and
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Dermatologic_and_Ophthalmic_Drugs_Advisory_Committee
date created:
date modified:
2022-11-17T06:43:21Z
main entity:
{"identifier":"Q5262698","url":"https://www.wikidata.org/entity/Q5262698"}
image:
fields total:
13
integrity:
13